Invention Grant
- Patent Title: Inhibitors of lysine specific demethylase-1
-
Application No.: US16007937Application Date: 2018-06-13
-
Publication No.: US10654810B2Publication Date: 2020-05-19
- Inventor: Young K. Chen , Toufike Kanouni , Stephen W. Kaldor , Jeffrey Alan Stafford , James Marvin Veal
- Applicant: CELGENE QUANTICEL RESEARCH, INC.
- Applicant Address: US CA San Diego
- Assignee: CELGENE QUANTICEL RESEARCH, INC.
- Current Assignee: CELGENE QUANTICEL RESEARCH, INC.
- Current Assignee Address: US CA San Diego
- Agency: Foley & Lardner LLP
- Main IPC: C07D239/47
- IPC: C07D239/47 ; A61K31/4545 ; A61K31/513 ; C07D401/14 ; C07D405/14 ; C07D401/12 ; C07D403/04 ; C07D403/12 ; C07D401/04 ; C07D471/10 ; C07B59/00 ; C07D239/36 ; C07D403/14 ; A61K31/5377 ; A61K31/551
Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.
Public/Granted literature
- US20180325900A1 INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 Public/Granted day:2018-11-15
Information query
